In Conversation

"It is not very common to run a biotech company of our size - currently we employ 90 experts capable of running the operations across the world."

"Médica Sur was founded with the intention of developing a concept that was already established in leading markets such as Europe and the US and that…

"In 2016, indicators clearly showed that Ukraine’s economy was back to growth for the first time since 2013 while purchasing power has indeed been increasing since…

"We are following a different strategy than most companies involved in the CNS field – an area that has remained desperately static in recent decades, despite…

"The USA contributes about USD 90 billion a year to Indonesia’s GDP, or roughly 10 percent. This really highlights that America’s private sector is one of the…

"We see ourselves as experimental therapists and while we offer standard care to our patients, we also want to offer them the opportunity to access the…

"Taiwan undoubtedly holds a very experienced generics industry that has already reached international standards."

"I expect the development of blockchain technology to be as disruptive as the dawn of the Internet."

"Despite Japan’s efforts to improve translational research and bring academia closer to the industry, bioIPSeeds actually perfectly embodies the kind of pioneering tool that could benefit…

"There is a crucial need to develop Taiwan’s Open Innovation culture, as such collaborative approach encompassing both academia and the industry hasn’t yet been embedded deep…

"Our strategy was to build a completely safe, user-friendly digital platform that would gather together all discoveries and innovation coming from Taiwan’s research centers and universities."

"Our mission is to do the maximum to decrease infection in hospitals. Nomosocial infection is a “silent killer” that is not widely discussed; more people die…

We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here